[Increased risk of invasive bacterial infections after preventive mumps-measles-rubella vaccination?].
Wiersbitzky
S
S
Fachärztin für Allgemeinmedizin, Greifswald.
Bruns
R
R
Mentel
R
R
D002675:Child, Preschool; D004338:Drug Combinations; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D008297:Male; D008458:Measles Vaccine / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D012307:Risk Factors; D012411:Rubella Vaccine / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D012480:Salmonella Infections / Q000276:immunology*; D012486:Salmonella typhimurium / Q000276:immunology; D018805:Sepsis / Q000276:immunology*
D004338:Drug Combinations; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine
Erhöhtes Risiko für invasive bakterielle Infektionen nach Mumps-Masern-Röteln-Schutzimpfung?